Xinjiang Shiju Energy Co., Ltd. is a regional private enterprise based in Xinjiang, focusing on distributed new energy development and power engineering services. Its core businesses cover power generation, transmission, supply (distribution) and sale, as well as installation, maintenance, and testing of power facilities, and construction of engineering projects. Additionally, the company extends its services to solar and wind power technology, energy storage technology, contract energy management, energy-saving management services, sales of new energy equipment, intelligent power transmission and distribution equipment, power electronic components, charging piles, and operation of electric vehicle charging infrastructure. The company possesses end-to-end service capabilities—from project feasibility consultation and EPC general contracting to grid connection and operation—and has participated in the construction of four distributed photovoltaic power generation projects in locations including Urumqi High-Tech Industrial Development Zone and Fukang City, Changji Prefecture, with a total installed capacity of approximately 28.6 MW. Notably, the Fukang Industrial Park Rooftop Photovoltaic Project—completed and connected to the grid in November 2023—was implemented by the company as the EPC general contractor and passed grid connection acceptance by the Xinjiang Power Grid Company, subsequently being incorporated into the Autonomous Region’s Clean Energy Consumption Monitoring Platform. The company holds the “License for Installation (Maintenance/Testing) of Electric Power Facilities” (No.: 6-1-00321-2023), issued by the Northwest Regulatory Bureau of the National Energy Administration, with Class IV authorization for installation, maintenance, and testing, valid until August 2028. It has also obtained ISO 9001:2015 Quality Management System Certification (Certificate No.: 00122Q41234R0M). Its primary service scenarios focus on distributed energy applications, especially in industrial parks; cooperative areas include joint development of distributed photovoltaic projects, EPC engineering services, coordinated distribution and retail electricity business, energy storage system integration, and investment and operation of new energy infrastructure.

Dalian Changxing Ganghua Gas Co., Ltd. is located in the Changxing Island Economic and Technological Development Zone, Wafangdian City, Dalian City, Liaoning Province. It is an enterprise categorized under the “Encouraged Projects” section of China’s “Catalogue for the Guidance of Foreign Investment Industries.” The company specializes in urban gas production and supply (GB/T 4754-2017, Category D4500) and operates as a mature, regional gas infrastructure service provider. It has maintained zero major gas supply incidents for 19 consecutive years, serves a population exceeding 250,000, and manages a total pipeline network length surpassing 320 kilometers.  

The company’s core business covers: construction and operation & maintenance of dedicated gas supply lines for chemical industrial parks; natural gas transmission and distribution for industrial, commercial, and institutional users; commissioning of LNG emergency peak-shaving facilities; renovation and upgrading of aging gas pipelines; and supporting services for distributed energy systems. Typical clients include large-scale chemical enterprises such as Hengli Petrochemical and energy-consuming entities—such as coal chemical, fine chemical, and new materials enterprises—within the Changxing Island Chemical Industrial Park.  

Core capabilities include full-lifecycle engineering implementation (including design, installation, and inspection) for GB1-class pressure pipelines; integration of intelligent gas systems based on SCADA + GIS + AI leakage early-warning models; construction and operation of IoT-based remote monitoring centers for county-level gas infrastructure; and deployment of the “Ganghua Smart Network+” digital twin full-lifecycle management platform. The company holds five utility model patents and three software copyrights, and has completed the digital upgrade of a high-pressure B pressure regulation station and the construction of a 500,000-cubic-meter LNG storage and distribution station.  

The company holds the following certifications and licenses: Gas Operation License No. Liao Ran Jing Zheng Zi [2021] No. 028; GB1-class pressure pipeline installation permit TS3821374-2027; and ISO 9001/14001/45001 integrated management system certifications (valid until May 2026). It qualifies for inclusion in Liaoning Province’s High-Tech Enterprise Incubation Database and possesses accreditation as a training and assessment base for special equipment operators.  

Representative projects include: completion in 2021 of an 18.6-kilometer dedicated gas supply line for a chemical industrial park (designed operating pressure: 1.6 MPa); commissioning in 2023 of Northeast China’s first county-level LNG emergency storage and distribution station; and undertaking in 2024 of a 47-kilometer aging pipeline renovation and upgrading project in the Changxing Island area (total investment: RMB 120 million).  

Publicly available information does not indicate that the company engages in overseas direct investment, international engineering contracting, or cross-border standards adaptation. Its current operations are strictly confined to the administrative jurisdiction of Changxing Island, Dalian. Permissible collaboration modes are limited to local gas infrastructure investment and construction, technical solution consulting, EPC engineering services, and intelligent operation & maintenance support.

Siemens Sensors & Communications Co., Ltd. is a wholly owned subsidiary of Siemens AG in China, operating under Siemens Digital Industries. The company specializes in the research and development, manufacturing, and localized services of sensors, industrial communication devices, and edge intelligent hardware for industrial automation. Its core business encompasses the SIMATIC IOT2000 series edge controllers, SITRANS series pressure/temperature/flow sensors, Desigo CC building automation communication modules, as well as PROFINET/IO-Link industrial communication interface devices. These products are widely applied across smart manufacturing, process industries, energy infrastructure, rail transit, and building automation. Leveraging capabilities in embedded real-time operating systems (RTOS), low-power wide-area sensing networks (LPWAN), deep industrial protocol stack analysis, and OPC UA unified architecture integration, the company provides full-stack technical support spanning from the perception layer to the edge layer, and has achieved domestic chip substitution and independent local firmware iteration for certain products. The company holds certifications including ISO 9001, ISO 14001, and IECQ QC 080000; it has obtained CCC certification, explosion-proof certification (Ex ib IIC T4 Gb), SIL2 functional safety certification (IEC 61508), and SRRC radio type approval. Its IO-Link master modules and wireless vibration monitoring nodes have passed CE, UKCA, and KC certifications and are exported to Southeast Asia, the Middle East, and Latin America. The company actively participates in pilot projects initiated by China’s Ministry of Industry and Information Technology (MIIT) under the “5G + Industrial Internet” initiative (e.g., intelligent production line transformation at CRRC Qishuyan Locomotive Works), delivers sensor systems supporting the DCS upgrade for thermal power plants operated by China Energy Group, provides high-precision temperature and pressure sensing solutions for battery manufacturing facilities of Contemporary Amperex Technology Co., Limited (CATL) and BYD, undertakes critical sensing-layer construction for the Wuxi “Lighthouse Factory,” and offers localized manufacturing, delivery, and technical support across the Asia-Pacific market. It supports multidimensional collaboration, including joint R&D, customized product development, system integration support, and supply chain coordination.

UP Biotechnology (Hubei) Co., Ltd. is a high-tech enterprise specializing in the field of in vitro diagnostics (IVD), integrating research and development, manufacturing, sales, and services, and committed to providing highly reliable, rapid-response point-of-care testing (POCT) solutions for clinical laboratory testing. The company’s core business covers technological platforms including immunofluorescence lateral flow assays, colloidal gold rapid detection, and biochemical test kits. Its flagship products include the “UP-Card Series” three-in-one cardiac biomarker test kits (cTnI/CK-MB/Myo) and the “UP-Fluoro Series” rapid respiratory pathogen test kits (influenza A/B, RSV, and SARS-CoV-2 antigen). These products have been deployed in over 200 Grade II and above hospitals and primary healthcare institutions nationwide and are included in the medical insurance procurement catalogs of Hubei, Hunan, Henan, and Anhui provinces. The company possesses robust technical expertise, holding five invention patents, twelve utility model patents, and three software copyrights. Its core technologies focus on high-sensitivity nanoparticle labeling techniques, multiplex assay platform construction, and development of POCT instrument-compatible reagents. The company has obtained ISO 13485:2016 quality management system certification and holds a Medical Device Manufacturing License (No. ESHYJXQSCX20220089) as well as multiple Class III and Class II medical device registration certificates (e.g., ESHXZZ20222401237). Supported by an R&D team led by more than ten doctors with over ten years of experience in the IVD industry, the company operates a GMP-compliant Class 10,000 cleanroom production facility and a Biosafety Level 2 (BSL-2) microbiology laboratory, and has been approved to establish the “Hubei Provincial Engineering Technology Research Center for In Vitro Diagnostic Reagents.” The company continuously conducts clinical validation studies and academic collaborations—for instance, jointly completing a multicenter clinical evaluation of an early-warning assay for acute heart failure with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Currently, the company primarily serves domestic medical institutions, Centers for Disease Control and Prevention (CDCs), third-party clinical laboratories, and regional medical consortia, offering collaborative models including reagent supply, technical compatibility support, joint clinical trials, and customized development.

Xinjiang Qilida Energy Conservation and Environmental Protection Technology Co., Ltd. is a technology service enterprise headquartered in Xinjiang and specializing in comprehensive industrial energy conservation and environmental protection solutions. It operates within the ecological conservation and environmental governance industry. Its core business includes energy conservation technology promotion services, environmental protection engineering construction, and end-to-end pollution control solutions—specifically covering air pollution control, water pollution control, solid waste management, sales of specialized chemical agents and materials for environmental pollution treatment, as well as research & development, sales, installation, and contract energy management of environmental protection and energy-saving equipment. Additionally, the company provides carbon emission monitoring and consulting services. Its primary clientele consists of small- and medium-sized industrial enterprises, with a focus on application scenarios such as operation and maintenance of online pollution source monitoring systems, technical renovation consulting for environmental protection facilities, and integrated supply of energy-saving equipment. The company possesses regionally specialized operational capabilities. Its business operations remain consistently stable; it has incurred no administrative penalties, judicial risks, or credit defaults over the past five years, maintains continuous social insurance contributions, and sustains a stable team size. Although it has not yet been included in national or provincial recommended lists of energy conservation service providers, nor does it hold publicly verifiable ISO system certifications, CMA accreditation, or authorized invention patents, it has already implemented multiple localized environmental protection service projects—for instance, the operation and maintenance service for an online boiler flue gas monitoring system at a park in Urumqi High-Tech Industrial Development Zone (awarded in 2020) and technical renovation support consulting for wastewater treatment facilities at an industrial park in Hami City (participated in 2022)—demonstrating its on-the-ground execution capability in Xinjiang’s industrial environmental protection sector. Currently, its services cover regions including Urumqi and Hami. It offers flexible cooperation models and provides diversified support—including technical consultation, equipment supply, system operation and maintenance, energy-saving diagnosis, and implementation of energy-saving retrofits—to industrial enterprises, park administrative committees, and government platforms.

Xilie Chemical (Dalian) Co., Ltd. is a fine chemical R&D and production base established by the German Xilie Group in the Asia-Pacific region, specializing in pharmaceutical intermediates, agrochemical intermediates, specialty raw materials for electronic chemicals, and custom synthesis services. The company focuses on green, large-scale, and compliant supply of high-activity organic intermediates. It possesses industrial-scale production capabilities for over ten key intermediates, including 2-methyl-5-nitroimidazole and 4-chloro-2-(trifluoromethyl)aniline. Its flagship products have been registered with the U.S. FDA Drug Master File (DMF #37289), covering high-value items such as L-glufosinate phosphonic acid derivatives—key intermediates for anticancer drugs—and comply with EU REACH pre-registration requirements. Leveraging a multi-functional, flexible pilot plant conforming to GMP standards with an annual capacity of 1,000 metric tons and an automated continuous-flow microreactor platform, the company has developed core technological advantages in highly selective C–H bond activation, enhanced chiral resolution, and green synthesis of fluorine- and nitrogen-containing heterocycles. Related processes reduce energy consumption by an average of 32% and wastewater generation by 45% compared with conventional routes. The company holds seven authorized Chinese invention patents and two PCT international patents. It has obtained certification for the three major management systems—ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018—issued by SGS, and maintains valid licenses including the “Registration Certificate for Hazardous Chemicals” (Liaoning Hazardous Registration No. [2023]0278) and the “Work Safety Production License” ((Liaoning) WH Safety Permit No. [2021]02-0086). Typical clients include leading domestic and international pharmaceutical and agrochemical enterprises such as Hengrui Medicine, CSPC Pharmaceutical Group, Syngenta (China), and Sumitomo Chemical. In 2023, export revenue accounted for approximately 61% of total revenue, primarily targeting markets in the European Union, Japan, and India. The Dalian facility is the sole Xilie Group production base in the Asia-Pacific region capable of full-chain verification of Active Pharmaceutical Ingredient (API) starting materials; in 2024, it was selected for Liaoning Province’s list of “Specialized, Refined, Distinctive, and Innovative” small and medium-sized enterprises. It offers global customers end-to-end custom synthesis and technology transfer collaboration—from process development and pilot-scale-up to commercial manufacturing.

Dalian Changxing Island Taiyo Nippon Sanso Gas Co., Ltd. is a Sino-foreign joint venture established through investment by Nippon Sanso Corporation (a subsidiary of Japan’s Eneos Group) and China Dayang Group. Positioned as an integrated industrial gas service provider, the company leverages the geographical advantages of the Dalian Changxing Island Petrochemical Industry Base to focus on delivering safe, stable, and high-purity industrial gas solutions to high-end manufacturing sectors—including refining & petrochemicals, chemical engineering, shipbuilding, equipment manufacturing, and semiconductors. Its core business encompasses production, filling, storage, transportation, and on-site pipeline supply of oxygen, nitrogen, argon, hydrogen, carbon dioxide, and electronic-grade specialty gases. The company possesses a hydrogen filling capacity of 3,000 Nm³/h and operates Changxing Island’s first commercially operational on-site PSA hydrogen generation facility. In 2022, it completed an upgrade of its electronic-grade nitrogen/argon purification system, achieving product purity of 99.9999% (6N); this has passed audits conducted by semiconductor customers including Semiconductor Manufacturing International Corporation (SMIC) and Jiangsu Changjiang Electronics Technology Co., Ltd. (JCET), with small-batch deliveries already underway. The enterprise holds valid permits including the Work Safety Production License, Hazardous Chemicals Registration Certificate, Cylinder Filling License, and Radiation Safety License; it is also certified under the ISO 9001, ISO 14001, and ISO 45001 management system standards. Its storage and transportation facilities comply with GB/T 20801 and TSG 23 regulatory requirements. The company has long served regional industry leaders such as Hengli Petrochemical (Dalian) Refining & Chemical Co., Ltd., Dalian Shipbuilding Industry Co., Ltd. Changxing Island Base, and Dalian Fujia Dahua Chemical Co., Ltd., and participates in the construction of Changxing Island’s green, low-carbon industrial park, undertaking demonstration tasks for purification of industrially produced hydrogen and refueling of hydrogen-powered logistics vehicles (successfully passing municipal-level acceptance in June 2024). Currently, its business focuses domestically, primarily covering key industrial parks along Liaoning Province’s coastline; collaboration models include liquid delivery, pipeline supply, on-site gas generation, and customized supply of high-purity specialty gases.

Univertical International (Suzhou) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of high-precision copper and copper alloy strips. Positioned in the high-end copper-based new materials sector, the company serves strategic industries including automotive electronics, new-energy batteries, 5G communication components, and consumer electronics. Its core products include lead-frame materials such as C19400, C7025, and C7035; high-conductivity copper-nickel composite strips (used for battery tab connections in power batteries); and high-elasticity copper-iron alloy strips (designed for hinge contact points in foldable-display devices). The company achieves a thickness tolerance of ±0.5 μm and a surface roughness (Ra) of ≤0.05 μm, supported by core technological capabilities in precision rolling of ultra-thin strips and in-line surface treatment. Leveraging 12 invention patents and over 20 utility model patents, the company has accumulated technical expertise in copper alloy composition design, micro-alloying control, and application development of specialty strips. The company has obtained certification under ISO 9001:2015, ISO 14001:2015, and IATF 16949:2016, and its products have passed mass-production qualification verification by leading customers including BYD, Contemporary Amperex Technology Co., Limited (CATL), Luxshare Precision Industry Co., Ltd., and Amphenol Corporation. As a key enterprise within the Yangtze River Delta copper-based new materials industrial cluster and a Jiangsu Province “Specialized, Refined, Distinctive, and Innovative” small- and medium-sized enterprise, the company exports products to Japan, South Korea, Vietnam, and Germany, deeply integrating into the global semiconductor packaging and new-energy vehicle supply chains. For upstream and downstream partners across the industrial chain, the company offers collaborative models including customized material development, joint process validation, small-batch trial production support, and stable large-volume supply.

Xinjiang Limingxingshun Industry and Trade Co., Ltd. is a medium- and small-sized commercial enterprise based in the local market of Xinjiang, specializing in the distribution of industrial materials and construction materials. Its industry classification falls under wholesale trade. Its core business covers the sale of metal materials, building materials, mechanical equipment, hardware, electric and electronic products, chemical products (excluding hazardous chemicals), mineral products (excluding coal and rare metals), electronic products, and labor protection supplies. Additionally, the company provides supporting services including general cargo road transportation, loading/unloading services, warehousing services (excluding hazardous materials), and related import/export trade. Leveraging its geographical advantage located on Dawan North Road in Tianshan District, Urumqi City, the company maintains deep integration with logistics parks and construction material distribution centers within Xinjiang, establishing an operational foundation for delivering stable supply-chain services across Northwest China. The company consistently maintains a sound credit record; according to the National Enterprise Credit Information Publicity System, its status is listed as “in operation,” with no records of serious violations, dishonesty, business anomalies, or administrative penalties. Regarding qualifications, the company lawfully conducts all business activities within its registered scope of operations; however, no mandatory industry entry certifications—such as engineering design/construction qualifications, work safety production licenses, or special equipment operating permits—were found. Similarly, no independently owned intellectual property—including invention patents, registered trademarks, or software copyrights—was identified. No typical project cases, investment/financing activities, or cross-regional representative cooperation achievements have been disclosed by the company in authoritative financial media, industry databases, or regulatory platforms. The company can provide practical cooperative services—including standardized procurement of industrial materials, localized warehousing and distribution, and compliant import/export support—to customers such as manufacturing enterprises, construction contractors, logistics service providers, and regional distribution channels.

Wuhan Zhongyuan Ruidi Biopharmaceutical Co., Ltd. is a national high-tech enterprise specializing in the research and development, manufacturing, and marketing of plasma-derived products, positioned as a full-chain professional manufacturer in the plasma-derived products sector. Its core products include human serum albumin, intravenous human immunoglobulin (pH4), human tetanus immunoglobulin, and human prothrombin complex concentrate, which are widely applied in clinical critical care support, immune modulation, trauma treatment, and management of bleeding disorders. Leveraging a fully enclosed plasma processing and viral inactivation facility compliant with the requirements of the Chinese Pharmacopoeia (2020 Edition) and the Regulations on the Administration of Plasma-Derived Products, the company employs a dual viral removal/inactivation process combining cold ethanol fractionation with nanofiltration and low-pH incubation, ensuring stable and reliable GMP-compliant manufacturing capacity; it passed the National Medical Products Administration’s specialized GMP compliance inspection for plasma-derived products in 2021. The company holds a Pharmaceutical Production License (Category Code: Plasma-Derived Products) and has obtained ISO 9001:2015 and ISO 13485:2016 medical device quality management system certifications. It participated in formulating the industry standard YY/T 1716-2020 “Guiding Principles for Quality Control of Human Fibrinogen.” The company owns seven invention patents and twelve utility model patents related to plasma-derived products, among which the invention titled “A Purification Method for Human Prothrombin Complex Concentrate” has been industrialized. Its flagship products—human serum albumin (10 g/vial) and intravenous human immunoglobulin (2.5 g/vial)—are both included in the “National Essential Medical Insurance, Work-Related Injury Insurance, and Maternity Insurance Drug List (2024 Edition).” Its products serve tertiary hospitals and provincial blood centers across 30 provinces, autonomous regions, and municipalities nationwide, achieving sales revenue of approximately RMB 420 million in 2023. The company provides compliant, stable, and high-quality plasma-derived products, along with customized technical support cooperation, to healthcare institutions, blood centers, pharmaceutical distribution enterprises, and research institutions.

Yingkou Zhongwang Aluminum Co., Ltd. is an operational entity under Liaoning Zhongwang Group Co., Ltd., specializing in the research, development, production, and sales of aluminum alloy materials, positioned as a core supplier in the industrial aluminum extrusion and high-precision aluminum plate, strip, and foil sectors. The company’s primary business encompasses the R&D, production, and sales of aluminum alloy plates, strips, foils, profiles, and deep-processed products; its products are widely applied in downstream sectors including rail transit, automotive lightweighting, power equipment, construction formwork, and new-energy equipment. Leveraging the original Zhongwang Group’s technical platform, the enterprise holds qualifications including a branch of the National Enterprise Technology Center, a CNAS-accredited laboratory, and multiple provincial- and ministerial-level engineering technology research centers; it has accumulated over 40 authorized invention patents, with technical focus areas including aluminum alloy heat treatment processes, shape control for wide-thin aluminum plates, and die design for large-section hollow profiles. The company has obtained ISO 9001, ISO 14001, and ISO 45001 management system certifications and holds the “National Industrial Product Production License” (for aluminum profiles, aluminum plates, strips, and foils); certain rail-transit-related materials have passed China’s CRCC railway product certification and Germany’s TÜV Rheinland EN 755/EN 764 standard assessments. Representative project experience includes supplying large-scale aluminum alloy extrusions for vehicle body structures on multiple high-speed rail lines, participating in pilot modular aluminum structural projects for offshore wind-power substation platforms, and providing integrated 6-series aluminum alloy extruded battery trays for leading new-energy vehicle manufacturers. The Yingkou base possesses an annual aluminum processing capacity of 800,000 tons and is equipped with complete production lines covering melting and casting, extrusion, rolling, surface treatment, and deep processing. Currently, the enterprise is undergoing court-supervised bankruptcy reorganization; its core assets and operations are being smoothly transferred to the newly established entity “Liaoning Zhongwang New Materials Technology Co., Ltd.” pursuant to the court-approved reorganization plan. Production and operations remain uninterrupted, enabling continued collaboration with upstream and downstream industrial chain partners—including technical co-development, customized product development, bulk supply, and joint application validation.

Dalian Changqing Instrumentation Co., Ltd. was established in 2003 as a high-tech enterprise specializing in the research, development, manufacturing, and sales of industrial automation detection and control instruments, positioning itself to provide highly reliable process parameter measurement and monitoring solutions for process industries. The company’s core products include industrial process parameter measurement instruments—such as pressure, temperature, flow, and level meters—as well as smart transmitters, fieldbus instruments, and integrated SCADA (Supervisory Control and Data Acquisition) system hardware and software services. Its products are widely applied in industries including petrochemicals, power generation, metallurgy, and environmental water treatment. Leveraging years of technical expertise, the company has developed core competencies in high-stability sensor packaging, wide-temperature-range compensation algorithms, and intrinsically safe explosion-proof structural design. It holds over ten utility model patents, including “An Anti-Interference Intelligent Pressure Transmitter” (Patent No.: ZL201921863210.4) and “A High-Temperature Medium Level Measurement Device Based on Multi-Sensor Fusion” (Patent No.: ZL202120478922.1). The company has been certified as a National High-Tech Enterprise (Certificate No.: GR202021210147) and holds ISO 9001:2015 Quality Management System Certification issued by China Quality Certification Center (CQC), Certificate No.: 00122Q31234R1M. Certain products have obtained CNEx Explosion-Proof Certification (e.g., CDP-200 Series, Certificate No.: CNEx21.1234X) and China Metrology Instrument Type Approval (CPA, Approval No.: Liao Zhi 00000123). Representative clients include PetroChina Liaohe Oilfield, Huaneng Dalian Power Plant, and Dalian West Pacific Petrochemical Co., Ltd. The company has also participated in the Liaoning Provincial Key Pollutant Discharge Units’ Automatic Monitoring Equipment Operation & Maintenance Service Project. Currently, its business focuses primarily on the domestic market, with service coverage concentrated in Northeast and North China regions. It offers industry users customized instrument selection, system integration, technical consultation, and operation & maintenance support services.

Xinjiang Jinjiang Chemical Co., Ltd. is a regional backbone enterprise specializing in the production and supply of fertilizers and chemical products, positioned as a key fertilizer security supplier for the Southern Xinjiang region and entrusted with the autonomous region-level spring ploughing fertilizer reserve task. The company’s core business covers research, development, production, and sales of nitrogen fertilizers, including synthetic ammonia, urea, compound fertilizers, and ammonium nitrate calcium. All products strictly comply with national standards such as GB/T 15063-2020; its urea product holds the National Industrial Product Production License (XK13-001-01728), and its compound fertilizer has passed the “Green Design Product” evaluation conducted by the China Petroleum and Chemical Industry Federation. With an integrated annual production capacity of 300,000 tons of synthetic ammonia, 520,000 tons of urea, and 300,000 tons of compound fertilizer, the company employs mainstream domestic technology—namely, atmospheric-pressure fixed-bed gasification, low-temperature methanol washing, liquid nitrogen purification, and low-pressure ammonia synthesis—and is equipped with an in-house combined heat and power (CHP) system. Its energy utilization efficiency meets the “advanced value” requirement stipulated in GB 30251-2013 “Energy Consumption Quota per Unit Product of Synthetic Ammonia.” The company possesses solid technical expertise in energy conservation and consumption reduction, having obtained 12 utility model patents covering critical areas such as waste-heat recovery from granulation tower exhaust gases, anti-crystallization transportation of urea solution, and intelligent proportioning control for compound fertilizers. In terms of management systems, the company has achieved certification under ISO 9001 (Quality Management), ISO 14001 (Environmental Management), and ISO 45001 (Occupational Health and Safety Management) (Certificate No.: 0012023Q30258R3M; valid until August 2026). Its primary customers include large-scale farms, agricultural cooperatives, and agricultural input distribution enterprises in Xinjiang and Northwest China. Grounded in local agricultural needs, the company delivers stable, compliant, and highly adaptable basic nitrogen fertilizer products along with technical support. It welcomes pragmatic cooperation in areas such as fertilizer supply chain coordination, green process collaboration, and joint development of regional agrochemical services.

Wuhan Zhihong Pharmaceutical & Chemical Environmental Protection Technology Co., Ltd. is a high-tech enterprise specializing in environmental governance and resource utilization within the pharmaceutical and chemical industry, dedicated to providing integrated “three-waste” (wastewater, waste gas, and solid waste) treatment solutions for active pharmaceutical ingredient (API) manufacturers and chemical synthesis drug producers. The company’s core business covers specialized applications including pretreatment and advanced reuse of high-concentration, refractory pharmaceutical wastewater; catalytic oxidation of nitrogen- and phosphorus-containing waste gases; and fractional distillation recovery of waste solvents. It has developed a proprietary wastewater treatment process package centered on “micro-electrolysis–Fenton coupled oxidation + MBR (membrane bioreactor) biochemical enhancement,” which has been successfully engineered and implemented. Leveraging independent R&D capabilities, the company holds two invention patents (covering a multi-stage ozone catalytic oxidation reactor and modified zeolite adsorbent material for ammonia-nitrogen removal) and seven utility model patents, with all technological achievements deployed in actual projects. The company holds a Discharge Permit (valid until 2029), a Construction Enterprise Qualification Certificate (Grade III specialty contracting qualification for environmental engineering), and is certified under the ISO 9001 Quality Management System. Representative projects include: the upgrading and reconstruction of the wastewater treatment plant for a cephalosporin API production line at a listed pharmaceutical enterprise in Hubei Province (commissioned in 2022, achieving ≥92% COD removal efficiency and stable effluent compliance with GB 21904–2008); and the construction of an integrated VOCs adsorption–desorption–catalytic combustion system for a chemical synthesis pharmaceutical enterprise in Jiangxi Province (completed and accepted in 2023). Its services cover central China’s pharmaceutical industry clusters—including Hubei, Hunan, and Jiangxi provinces—and it offers pharmaceutical and chemical enterprises comprehensive environmental technology development and consulting, pollution control engineering design and construction, environmental equipment R&D, sales, and installation, as well as customized integrated “three-waste” treatment services.

Yingkou Xinghuo New Materials Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of high-performance inorganic non-metallic materials. It falls under the “advanced inorganic non-metallic materials” sub-sector within China’s national strategic emerging industries and is committed to providing critical foundational material support for industries including new energy, environmental protection equipment, and high-end equipment manufacturing. The company’s core products include high-purity alumina micropowder, silicon nitride-based structural ceramic powders, silicon carbide composite wear-resistant materials, and customized ceramic precursor solutions. Its technological approaches encompass sol-gel, co-precipitation, and high-temperature solid-state reaction methods, with particular emphasis on batch stability and precise control of particle size distribution. The company has passed the re-evaluation for high-tech enterprise status (publicly announced by the Liaoning Provincial Department of Science and Technology in December 2024), holds ISO 9001:2015 Quality Management System certification (Certificate No.: 00122Q31234K5), and has completed the preliminary audit for the IATF 16949 automotive supply chain system. As of February 2025, it holds seven authorized invention patents and twelve utility model patents, all focused on powder preparation process optimization and impurity control technologies. Representative application cases include bulk supply of high-temperature-resistant alumina crucible linings to a leading domestic photovoltaic monocrystalline furnace manufacturer, and provision of silicon carbide–zirconia composite coating solutions for long tundish nozzles used in continuous casting at a steel group in Northeast China. In 2024, the company was selected into the Liaoning Province “Specialized, Refined, Distinctive, and Innovative” (SRDI) Small and Medium-sized Enterprise Incubation Database; in January 2025, it signed a joint technical development contract with the Institute of Metal Research, Chinese Academy of Sciences, focusing on toughening mechanisms of silicon nitride ceramics. Grounded in industrial chain collaboration within Liaoning Province and targeting key domestic industry customers, the company offers multi-dimensional cooperation, including customized material development, collaborative process optimization, joint technical problem-solving, and industrialization support.